Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Free light chains in multiple sclerosis urine

P D Mehta1, S D Cook, P K Coyle

  • 1Department of Immunology, New York State Institute for Basic Research in Developmental Disabilities, Staten Island 10314-6399, USA.

Multiple Sclerosis (Houndmills, Basingstoke, England)
|October 8, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Should Age 65 be a cutoff for Primary Progressive Multiple Sclerosis therapy? Real World Data is Critical.

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics·2023
Same author

Common Neurologic Features of Lyme Disease That May Present to a Rheumatologist.

Pathogens (Basel, Switzerland)·2023
Same author

Easy to interpret coordinate based meta-analysis of neuroimaging studies: Analysis of brain coordinates (ABC).

Journal of neuroscience methods·2022
Same author

Beta interferons as immunotherapy in multiple sclerosis: a new outlook on a classic drug during the COVID-19 pandemic.

QJM : monthly journal of the Association of Physicians·2021
Same author

Coordinate based meta-analysis of networks in neuroimaging studies.

NeuroImage·2019
Same author

Mdivi-1, a mitochondrial fission inhibitor, modulates T helper cells and suppresses the development of experimental autoimmune encephalomyelitis.

Journal of neuroinflammation·2019
Same journal

UK consensus on pregnancy in multiple sclerosis: An update to 'Association of British Neurologists' guidance.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same journal

Comparative effectiveness of rituximab versus ocrelizumab in relapsing multiple sclerosis on clinical relapses and radiological outcomes in British Columbia, Canada.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same journal

Invisible symptoms in multiple sclerosis and their impact on social role participation: A multidimensional analysis.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same journal

Interaction between smoking and <i>HLA-A*02:01</i> in multiple sclerosis progression.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same journal

Impact of multiple sclerosis disease-modifying therapies on chronic lesion tissue expansion.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same journal

Tobacco smoking disrupts bile acid and tryptophan metabolism in multiple sclerosis.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
See all related articles

Urinary kappa and lambda light chains are elevated in multiple sclerosis (MS) patients. Levels correlated with disease activity in relapsing-remitting MS, but not progressive MS, suggesting potential diagnostic relevance.

Area of Science:

  • Neurology
  • Immunology
  • Biochemistry

Background:

  • Multiple Sclerosis (MS) is a chronic neurological disease.
  • Understanding biomarkers for MS activity is crucial.
  • Free light chains (FLCs) are immunoglobulin components.

Purpose of the Study:

  • To investigate urinary free kappa and lambda light chains as potential biomarkers in multiple sclerosis.
  • To correlate FLC levels with disease status and activity.

Main Methods:

  • Enzyme-linked immunosorbent assay (ELISA) was used to measure urinary kappa and lambda light chains.
  • Patients included definite multiple sclerosis (MS), other neurologic diseases (OND), and normal controls.
  • Serial measurements were performed in relapsing-remitting (R-R) and progressive (P) MS subtypes.

Related Experiment Videos

Main Results:

  • Urinary kappa and lambda light chains were significantly higher in MS patients compared to OND and controls.
  • In R-R MS, elevated urinary kappa chains correlated with disease worsening and decreased during recovery.
  • Urinary kappa chain levels did not correlate with clinical activity in P MS patients.

Conclusions:

  • Urinary free light chains may serve as a potential biomarker for multiple sclerosis.
  • The correlation with clinical activity differs between relapsing-remitting and progressive MS subtypes.
  • Further research is needed to establish the clinical and biological relevance of urinary light chains in MS.